Skip to content
Search

Latest Stories

Project to predict cardiovascular events receives heart charity grant

A Manchester University project to help predict the risk of cardiovascular events has received a grant of nearly £150,000 from Heart Research UK.

A team, led by Prof Mamas Mamas, will use medical data to develop a tool that predicts the risk of a future cardiovascular event or death in people who have already had a heart attack.


In the UK, around seven million people live with CVD, which is responsible for one in four deaths.

People living with underlying heart conditions are up to five times more likely to have a stroke and are six times more likely to die compared to those without.

Up to half of these patients suffer a second heart attack.

The project is significant because there are currently no methods to predict the risk in this group of patients and improve their care.

Prof Mamas hailed it as an “an incredibly exciting project” which “will be able to make a real difference to survivors of heart attacks.”

“If we can accurately predict the likelihood of them suffering another cardiovascular event, then we can intervene early and hopefully reduce their risk. This will not only help to improve their quality of life, but could ensure that patients receive care tailored to their condition, increasing its effectiveness and helping to reduce the strain on our health service,” he said.

The £147,816 grant was awarded to the University of Manchester as part of the national charity’s annual awards for research into the prevention, treatment and cure of heart diseases.

Kate Bratt-Farrar, Chief Executive of Heart Research UK, said: “We are delighted to be supporting the work of Prof Mamas and his team, which has the potential to have a big impact on how effective we can be at preventing people suffering from a cardiovascular event."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less